Publication|Articles|April 10, 2026
- Pharmaceutical Executive: April 2026
- Volume 46
- Issue 3
Pharmaceutical Executive: April 2026 Interactive Digital Edition
View the Pharmaceutical Executive April 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 month ago
Capital Gainsabout 1 month ago
Aradhana Sarin: The CFO as a Catalystabout 1 month ago
How Agentic AI Is Reshaping the Launch Playbook for PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
GLP-1 Patent Expiry & the Rise of Generics: Transforming the Drug Delivery Device Landscape & Procurement Strategy
2
FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection
3
President Trump Planning to Fire FDA Commissioner Marty Makary: Report
4
Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals
5
